4Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions[J]. Arch Intem Med, 2005, 165(10): 1095-1106. 被引量：1
5Higashi MK, Veenstra DL, Kondo LM, et al. Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy[J]. JAMA,2002, 287(13): 1690-1698. 被引量：1
6Margaglione M, Colaizzo D, Andrea GD, et al. Genetic modulation of oral anticoagulation with warfarin [J].Thromb Haemost, 2000, 84(5):775-778. 被引量：1
7Voora D, Eby C, Linder MW, et al. Prospective dosing of warfarin based on cytochrome P4502C9 genotype[J].Thromb Haemost, 2005, 93(4):700-705. 被引量：1
8Voom D, Mcleod HL, Eby C, et al. Use of pharmacogenetics to guide warfarin therapy[J]. Drugs Today, 2004,40(3): 247-257. 被引量：1
10Schaefer MG, Plowman BK, Morrerle AP, et al. Interaction of rofecoxib and celecoxib with warfarin [J]. Am J Health Syst Pharm, 2003, 60(13): 1319-1323. 被引量：1
